ERCP in Idiopathic Recurrent Acute Pancreatitis

Completed · Not applicable · Has a placebo group

Conditions studied: Recurrent Acute Pancreatitis

In brief

The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).

Key facts

Study ID

NCT01583517

Run by

Indiana University

People needed

89

Starts

1997-09-01

Expected to finish

2014-10-01

Last updated by the study team

2014-10-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Idiopathic recurrent acute pancreatitis, defined as two or more episodes requiring hospitalization
• ERCP with SOM planned

You may not qualify if…

• Chronic pancreatitis
• Pancreas divisum
• Alternate etiology identified (e.g., CBD stone, IPMN)
• Inability to perform pancreatic manometry
• Pregnancy, age < 18, incarceration
• Inability to provide informed consent

Where it is running

• Indiana University Health University Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.